Logo image of ZYME

ZYMEWORKS INC (ZYME) Stock Analyst Earnings Estimates

NASDAQ:ZYME - Nasdaq - US98985Y1082 - Common Stock - Currency: USD

12  -0.13 (-1.07%)

After market: 12 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ZYME revenue by date.ZYME revenue by date.
26.7M
-31.54%
412.5M
1,444.94%
76.012M
-81.57%
92.381M
21.53%
91.453M
-1.00%
182.96M
100.06%
150.75M
-17.60%
184.92M
22.67%
246.72M
33.42%
361.98M
46.72%
345.78M
-4.48%
592.62M
71.39%
EBITDA
YoY % growth
ZYME ebitda by date.ZYME ebitda by date.
-209.1M
-16.23%
137.7M
165.85%
-127.889M
-192.88%
-147.604M
-15.42%
-130.15M
11.82%
-102.991M
20.87%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ZYME ebit by date.ZYME ebit by date.
-215.6M
-14.99%
130.5M
160.53%
-138.053M
-205.79%
-128.062M
7.24%
-138.899M
-8.46%
-68.373M
50.78%
-135.748M
-98.54%
-107.093M
21.11%
-40.87M
61.84%
77.376M
289.32%
146.88M
89.83%
398.82M
171.53%
Operating Margin
ZYME operating margin by date.ZYME operating margin by date.
-807.49%31.64%-181.62%-138.62%-151.88%-37.37%-90.05%-57.91%-16.57%21.38%42.48%67.30%
EPS
YoY % growth
ZYME eps by date.ZYME eps by date.
-4.11
-14.80%
1.93
146.96%
-1.73
-189.64%
-1.47
19.65%
-1.75
-25.65%
-1.02
41.79%
-1.70
-67.56%
-1.55
9.28%
-0.67
56.44%
0.52
177.27%
1.37
162.75%
3.63
165.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.48
-13.54%
-0.47
-73.78%
-0.39
-0.69%
-0.43
-39.02%
Revenue
Q2Q % growth
12.342M
23.05%
15.81M
-17.84%
28.56M
78.50%
25.738M
-17.05%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-42.383M
-12.12%
-40.715M
-59.05%
-31.874M
6.82%
-36.009M
-148.39%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
-0.31
-55.00%
-0.10-0.21-206.99%
Q3 2024
Q2Q % growth
-0.39
4.88%
-0.400.013.34%
Q2 2024
Q2Q % growth
-0.27
64.47%
-0.320.0516.42%
Q1 2024
Q2Q % growth
-0.42
-16.67%
-0.30-0.12-41.99%
Q4 2023
Q2Q % growth
-0.20
-104.30%
-0.440.2454.79%
Q3 2023
Q2Q % growth
-0.41
43.06%
-0.480.0714.36%
Q2 2023
Q2Q % growth
-0.76
21.65%
-0.48-0.28-58.39%
Q1 2023
Q2Q % growth
-0.36
65.05%
-0.550.1934.22%
Q4 2022
Q2Q % growth
4.65
711.84%
4.94-0.29-5.81%
Q3 2022
Q2Q % growth
-0.72
38.46%
-0.940.2223.34%
Q2 2022
Q2Q % growth
-0.97
25.95%
-0.980.011.26%
Q1 2022
Q2Q % growth
-1.03
-18.39%
-1.700.6739.39%
Q4 2021
Q2Q % growth
-0.76
-2.70%
-1.160.4034.70%
Q3 2021
Q2Q % growth
-1.17
18.18%
-1.190.021.69%
Q2 2021
Q2Q % growth
-1.31
-70.13%
-1.07-0.24-22.15%
Q1 2021
Q2Q % growth
-0.87
-35.94%
-1.050.1817.46%
Q4 2020
Q2Q % growth
-0.74
55.42%
-1.250.5140.70%
Q3 2020
Q2Q % growth
-1.43
-104.29%
-0.93-0.50-54.53%
Q2 2020
Q2Q % growth
-0.77
10.47%
-0.880.1112.05%
Q1 2020
Q2Q % growth
-0.64
-48.84%
-1.090.4541.27%
Q4 2019
Q2Q % growth
-1.66 -0.88-0.78-88.30%
Q3 2019
Q2Q % growth
-0.70 -0.780.0810.04%
Q2 2019
Q2Q % growth
-0.86 -0.68-0.18-27.04%
Q1 2019
Q2Q % growth
-0.43 -0.550.1221.90%
ZYME Yearly EPS VS EstimatesZYME Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
31.03M
83.33%
46.104M-15.074M-32.70%
Q3 2024
Q2Q % growth
16M
-3.07%
15.609M391K2.50%
Q2 2024
Q2Q % growth
19.243M
174.82%
20.494M-1.251M-6.10%
Q1 2024
Q2Q % growth
10.03M
-71.81%
17.78M-7.75M-43.59%
Q4 2023
Q2Q % growth
16.926M
-95.79%
15.758M1.168M7.41%
Q3 2023
Q2Q % growth
16.506M
534.85%
10.373M6.133M59.12%
Q2 2023
Q2Q % growth
7.002M
29.67%
12.607M-5.605M-44.46%
Q1 2023
Q2Q % growth
35.578M
1,772.53%
19.916M15.662M78.64%
Q4 2022
Q2Q % growth
402.5M
1,922.61%
378.73M23.77M6.28%
Q3 2022
Q2Q % growth
2.6M
-40.91%
4.047M-1.447M-35.75%
Q2 2022
Q2Q % growth
5.4M
200.00%
6.197M-797K-12.86%
Q1 2022
Q2Q % growth
1.9M
216.67%
3.536M-1.636M-46.27%
Q4 2021
Q2Q % growth
19.9M
26.75%
9.315M10.585M113.63%
Q3 2021
Q2Q % growth
4.4M
69.23%
7.487M-3.087M-41.23%
Q2 2021
Q2Q % growth
1.8M
-85.48%
7.24M-5.44M-75.14%
Q1 2021
Q2Q % growth
600K
-92.77%
7.257M-6.657M-91.73%
Q4 2020
Q2Q % growth
15.7M
726.32%
10.506M5.194M49.44%
Q3 2020
Q2Q % growth
2.6M
-67.09%
12.978M-10.378M-79.97%
Q2 2020
Q2Q % growth
12.4M
56.96%
8.28M4.12M49.76%
Q1 2020
Q2Q % growth
8.3M
-30.25%
7.909M391K4.94%
Q4 2019
Q2Q % growth
1.9M 9.667M-7.767M-80.35%
Q3 2019
Q2Q % growth
7.9M 8.678M-778K-8.97%
Q2 2019
Q2Q % growth
7.9M 4.463M3.437M77.01%
Q1 2019
Q2Q % growth
11.9M 4.08M7.82M191.67%
ZYME Yearly Revenue VS EstimatesZYME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 19.79% 0% 1.46%
Revenue0% 4.1% 0% 1.84%